MICROBE 2018 225 A comparison of piperacillin-tazobactam and colisitn ComASP (Sensi test) MIC to CLSI Broth Microdilution MIC for Gram Negative challenge Isolates

MICROBE 2018 226 Development of CLSI MIC and DISK diffusion quality control ranges for Cefepime VNRX-5133

MICROBE 2018 240 Multi-Site Evaluation of Meropenem Vaborbactam MIC test strip (MTS) Compared to Broth Microdilution MICs

MICROBE 2017 423 Comparison of Delafloxacin MIC test strip and Broth microdilution MIC results for Staphylococcus spp., E. facalis, Enterobacteriaceae and P. aeruginosa

ECCMID 2016 P0799 Evaluation of ceftazidime-avibactamgradient strip MIC, broth microdilution MIC and 10-4 disk methods for Enterobacteriaceaeand Pseudomonas aeruginosaL

MICROBE 2016 P032 Evaluation of Ceftolozane-tazobactam MIC test strip compared to broth microdilution MIC for Enterobacteriaceae and Pseudomonas aeruginosa

MICROBE 2016 022 Multi-Site Evaluation of Dalbavancin and Vancomycin MIC test strip compared to Broth Microdilution MICs

MICROBE 2016 321 Evaluation of Oxyrase Agar media for growth and selection of anaerobic isolates

ECCMID 2016 P0818 Evaluation of Tedizolid Liofilchem MIC Test Strips A Comparison to

ECCMID 2015 EP177 A multicenter ceftaroline 5ug Disk Study of Staphylococcus aureus

ICAAC 2015 D-1138 Evaluation of Dalbavancin MIC test strip MTS compared to Broth microdilution MIC for relevant gram positive isolates

ECCMID 2015 P1295 EUCAST quality control criteria for the ceftazidime-avibactam 10-4ug disk

ECCMID 2015 EP178 A Multicenter Comparison Study of Various Ceftaroline MIC-Based Methods for Staphylococcus aureus

ICAAC 2014 F-280 Analysis of MIC testing methods and variables for GSK2140944 and Levofloxacin against gram-neg and gram-pos bacterial isolates

ICAAC 2014 F-281 Analysis of disk testing methods and variables for GSK214944 and linezolid against Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes

ICAAC 2014 F-1596 Analysis of MIC testing mehtods and variables for GSK1322322 and comparators against S. pneumoniae, H. influenzae, S. pyogenes and Moraxella catarrhalis

ICAAC 2014 F-1597 Analysis of disk testing methods and variables for GSK1322322 and comparators against S. aureur, H. influenzae, S. pneumoniae and S. pyongens

ICAAC 2014 D-877 Dalbavacin and Azithromycin Synerg Antagonism Study by Checkerboard MIC

ICAAC 2014 D-859 Standardization of a modified broth microdilution methodology of Dalbavancin against Neisseria gonorrhoeae

ECCMID 2014 P-0221 Ceftazidime-avibactam disk mass studies for EUCAST disk diffusion methos against Enterobacteriaceae and Pseudomonas aeruginosa

Keystone Symposia Poster 219 Frequency and Distribution of Mutations in mprF In Daptomycin Nonsusceptible Saureus Clinical Isolates

IDSA 2013 P-255 In vitro activity of dalbavancin against Neisseria gonorrhoeae and development of a broth microdilution method

ECCMID 2013 P-1602 Comparison of EUCAST and CLSI ceftaroline minimum inhibitory concentration (MIC) for H. influenzae and S. pneumoniae

ASM 2012 Poster 132 Comparison of Broth Microdilution and Agar Dilution Dalbavancin and Vancomycin MIC results for 42 Aerobic Gram-positive Bacteria

CMI ECCMID 2012 abstract (R2518) in CMI (poster not presented) p.753

ICAAC 2012 E-802 The Effect of Urine, Lung Surfactant and Testing Parameter Variations on the In Vitro Activity of GSK2251052 and Meropenem

ICAAC 2011 E-127 A Comparison of Broth Microdilution and Agar Dilution for GSK2251052 and Meropenem Against Gram-Negative Organisms and B. fragilis

ECCMID 2011 P-1066 In vitro multisite study of vancomycin and daptomycin MIC results and tolerance of contemporary S. aureus from Spain

ECCMID 2011 P-1065 Multisite evaluation of the daptomycin Neo-Sensitab prediffusion method against 20 S. aureus.pdf

ASM 2010 C-114 Variation in Vancomycin Tolerance Determination among

ICAAC 2010 D-1522 The Effect of Testing Parameter Variations on the In VitroActivity of GSK1322322 and Linezolid

ICAAC 2009 D-790 Effect of Serum and Albumin on MIC and MBC of Daptomycin

ICAAC 2009 E-1466 Synergy of Polyphenon ER with Cefuroxime against

ICAAC 2009 In vivo Activity of a DnaK Inhibitor Alone and in Combination with Levofloxacin

ICAAC 2009 The First Biologically Active Small Molecule Bacterial HSP70 (DnaK) Inhibitors

ICAAC 2008 D-2230 A Comparison of ceftobiprole and ceftazidime MICs by European methods against 125 Gram-positive and Gram-negative organisms

ICAAC 2008 D-2227 A Comparison of doripenem and meropenem MICs by European methods against 109 Gram-positive and Gram-negative organisms

ICAAC 2008 D-2221 Comparison of daptomycin Etest MICs on European Mueller Hinton and IsoSensitest agars against 20 Staphylococcus aureus

ICAAC 2008 F1-2050 Activity of Levofloxacin Alone and in Combination with a DnaK Inhibitor Against Gram-negative Rods, Including Levofloxacin Resistant Strains

ECCMID 2008 P-593 Comparison of daptomycin Etest MICs on MHA, ISA and BHI agars with and without calcium supplementation to broth microdilution MICs against 20 Staphylococcus aureus

ECCMID 2007 P-1631 Moxifloxacin MIC results for Neisseria gonorrhoeae (ATCC 49226) for an eight lab study by CLSI agar dilution methodology

ICAAC 2007 D-886 Comparison of vancomycin and teicoplanin disk and agar screen procedures for detection of vancomycin intermediate S. aureus

ICAAC 2007 A-1439 Insufficient activity of most common antistaphylococcal antibiotics towards intraphagocytic forms of S. aureus from a patient with persistant bateriemia a cause for treatment failure

ICAAC 2007 D-245 The effect of testing parameter variations on the in vitro activity of iclaprim against Staphylococcus aureus

ICAAC 2006 D-0809 Comparison of Mupirocin 5 and 20 disk results to microdilution and Etest MICs against susceptible isolates and a resistant challenge set of S. aureus

ICAAC 2006 F2-1167 Synergistic in vitro activity of DnaK inhibitors and levofloxacin against Gram-negative organisms

ECCMID 2006 P-1442 Evaluation of effect of low concentration of calcium in daptomycin 30 mcg discs on IsoSensitest agar against staphylococcus

ECCMID 2006 P-1441 Evaluation of daptomycin 5, 10, and 15 mcg discs on IsoSensitest and Mueller Hinton agar against S. aureus

ICAAC 2005 Comparison of Daptomycin Etest MICs with Broth Microdilution MICs against a Challenge Set of 58 S. aureus and 44 Enterococcus spp

ICAAC 2005 F-2064 The Effect of Testing Parameter Variations on the In Vitro Activity of Retapamulin and Mupirocin

ASM 2004- Daptomycin disk diffusion testing Comparison of three Mueller Hinton agars, using disks from three manufacturers

ICAAC 2004 D-1921 Comparison of Daptomycin and Vancomycin MICs for 244 Gram-positive Strains Using IsoSensitest and Mueller Hinton Media

ECCMID 2004 P-1743 Comparison of daptomycin and vancomycin MIC results by NCCLS, SFM, DIN and SRGA

ECCMID 2004 P-1890 QC Study evaluating the performance of daptomycin and combination daptomycin calcium disks and Etest

ICAAC 2001 735 Activity of Gemifloxacin, Ciprofloxacin and Levofloxacin against 8,479 Respiratory Isolates Collected Worldwide in 1999 and 2000

ASM 2001- C-274 Activity of AmoxClav Acid and 16 Comparator Agents Against Respiratory Isolates, Collected Worldwide in 2000

ASM 2000- Gemifloxacin and Ciprofloxacin Susceptibility Testing Comparison of NCCLS Broth MIC Method with 5 MIC Methods

ICAAC 1998 C-19 Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae in 1997